Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Supernus Pharmaceuticals (SUPN)
Technical Analysis Report for USA stock SUPN Supernus Pharmaceuticals. Dated: 13 May 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock SUPN Supernus Pharmaceuticals then click here. or read Experts views on Supernus Pharmaceuticals or Forecast & share price targets of Supernus Pharmaceuticals
Supernus Pharmaceuticals Opened at 50.02 and Closed at: 51.36, which is 1.62% of previous session's close. It moved within a range of 50.02 and 51.50
The session was a Bullish session with an average volume of 432200, which is -36.4% of previous session's volumes.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Golden cross was found 2 days back on short term averages
Support for tomorrow is 50.69 and resistance for tomorrow is 52.17
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 50.42, 49.48 resistance for tomorrow's hourly charts is 51.9, 52.44
10 Day SMA for Supernus Pharmaceuticals (SUPN) is 50.36 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Supernus Pharmaceuticals (SUPN) is 50.03 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Supernus Pharmaceuticals (SUPN) is 50.62 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 50.69 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Supernus Pharmaceuticals is 48.42 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Supernus Pharmaceuticals is at 50.03 and 200 DMA is at 48.42, while 50 DMA and 100 DMA are at 50.62 and 50.69 respectively
Supernus Pharmaceuticals (SUPN) moving average of 20 SMA is at 50.03 and 20 EMA is at 50.3
| Date | Closing Price | 20 SMA | 20 EMA |
| 13 Wed May | 51.36 | 50.03 | 50.3 |
| 12 Tue May | 50.53 | 49.92 | 50.19 |
| 11 Mon May | 49.37 | 49.89 | 50.15 |
| 08 Fri May | 51.53 | 49.93 | 50.23 |
| 07 Thu May | 52.28 | 49.85 | 50.09 |
| 06 Wed May | 51.45 | 49.77 | 49.86 |
Supernus Pharmaceuticals (SUPN) moving average of 50 SMA is at 50.62 and 50 EMA is at 50.38
| Date | Closing Price | 50 SMA | 50 EMA |
| 13 Wed May | 51.36 | 50.62 | 50.38 |
| 12 Tue May | 50.53 | 50.69 | 50.34 |
| 11 Mon May | 49.37 | 50.77 | 50.33 |
| 08 Fri May | 51.53 | 50.9 | 50.37 |
| 07 Thu May | 52.28 | 51 | 50.32 |
| 06 Wed May | 51.45 | 51.02 | 50.24 |
Supernus Pharmaceuticals (SUPN) moving average of 100 SMA is at 50.69 and 100 EMA is at 49.84
| Date | Closing Price | 100 SMA | 100 EMA |
| 13 Wed May | 51.36 | 50.69 | 49.84 |
| 12 Tue May | 50.53 | 50.67 | 49.81 |
| 11 Mon May | 49.37 | 50.65 | 49.8 |
| 08 Fri May | 51.53 | 50.63 | 49.81 |
| 07 Thu May | 52.28 | 50.58 | 49.78 |
| 06 Wed May | 51.45 | 50.52 | 49.73 |
Supernus Pharmaceuticals (SUPN) moving average of 200 SMA is at 48.42 and 200 EMA is at 47.45
| Date | Closing Price | 200 SMA | 200 EMA |
| 13 Wed May | 51.36 | 48.42 | 47.45 |
| 12 Tue May | 50.53 | 48.33 | 47.41 |
| 11 Mon May | 49.37 | 48.25 | 47.38 |
| 08 Fri May | 51.53 | 48.16 | 47.36 |
| 07 Thu May | 52.28 | 48.07 | 47.32 |
| 06 Wed May | 51.45 | 47.97 | 47.27 |
Supernus Pharmaceuticals has performed better than Medtronic Plc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Edwards Lifesciences has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Edwards Lifesciences, about 0.55% more returns!
Supernus Pharmaceuticals has performed better than Boston Scientific in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Baxter International in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Riot Blockchain has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Riot Blockchain, about 37.66% more returns!
Supernus Pharmaceuticals has performed better than Repligen Corporation in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Radnet Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Ptc Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Ptc Therapeutics, about 1.48% more returns!
Supernus Pharmaceuticals has performed better than Intellia Therapeutics in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Nektar Therapeutics in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Incyte Corporation has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Incyte Corporation, about 1.08% more returns!
Genesis Healthcare has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Genesis Healthcare, about 15.82% more returns!
Establishment Labs has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Establishment Labs, about 3.04% more returns!
Supernus Pharmaceuticals has performed better than Cytomx Therapeutics in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Celldex Therapeutics in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Biolife Solutions in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Axsome Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 24.57% more returns!
Supernus Pharmaceuticals has performed better than Aurinia Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Arrowhead Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Arrowhead Pharmaceuticals, about 12.1% more returns!
Supernus Pharmaceuticals Technical analysis of indicators
Price action analysis of Supernus Pharmaceuticals (SUPN) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Supernus Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Supernus Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Supernus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Supernus Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.51 and Supernus Pharmaceuticals SUPN stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Supernus Pharmaceuticals SUPN stock. Volume based technical analysis of Supernus Pharmaceuticals SUPN stock is negative.
Supernus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock SUPN Supernus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SUPN Experts View which covers a lot of information including buying and selling signals
SUPN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Supernus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance


